Herceptin and early breast cancer: a moment for caution
http://www.thelancet.com/webfiles/im.../herceptin.pdf
I found this editorial from the Lancet, a very well-respected British medical journal, interesting, although a bit discomforting. As a relatively young patient with a good heart, I think I'll take my chances with continuing to pay for it (my oncologist was on the HERA trial board and I think he knows more than is publicly available), but the editorial does raise a number of concerns.